1 study found for:    23122652 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: alemtuzumab;   Biological: interferon beta-1a (Rebif®)

Indicates status has not been verified in more than two years